Open AccessProstate adenocarcinoma: a new integrated diagnostic approach aimed at the therapeutic choice
Author(s) -
A. Delle Fave,
Stefania Erra
Publication year - 2016
Publication title -
working paper of public health
Language(s) - English
Resource type - Journals
ISSN - 2279-9761
DOI - 10.4081/wpph.2016.6695
Subject(s) - prostate cancer , medicine , prostate , adenocarcinoma , cancer , prostatic adenocarcinoma , oncology , prostate adenocarcinoma , biopsy , presentation (obstetrics) , cd117 , pathology , radiology , biology , genetics , stem cell , cd34
Prostate cancer is different in clinical presentation, histopathological tumor growth, patterns and survival than others cancer. Therefore, individual assessment of a tumor’s aggressive potential is crucial for clinical decision-making in men with prostate cancer. Here we discuss the potential role of ERG and CD117 as a prognostic factors and molecular targets in needle biopsy on prostate cancer.